Barrington analyst Michael Petusky maintained a Buy rating on VerifyMe (VRME – Research Report) today and set a price target of $2.00. The company’s shares closed yesterday at $1.81.
According to TipRanks, Petusky is a 4-star analyst with an average return of 6.4% and a 51.88% success rate. Petusky covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, Merit Medical Systems, and Anika Therapeutics.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for VerifyMe with a $3.50 average price target.
See the top stocks recommended by analysts >>
The company has a one-year high of $2.82 and a one-year low of $1.01. Currently, VerifyMe has an average volume of 27.52K.
Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of VRME in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
VerifyMe, Inc. engages in the provision of digital and physical solutions. It is able to deliver security solutions for identification and authentication of people, products and packaging in a variety of applications in the security field for physical transactions and owns digital patents which are in the same field. The company was founded by Norman A. Gardner on November 10, 1999 and is headquartered in Rochester, NY.
Read More on VRME:
- VerifyMe Reports First Quarter 2023 Financial Results
- VerifyMe reports Q4 revenue $9.7M vs. $300,000 last year
- VerifyMe Reports Positive Net Income in Fourth Quarter 2022 Financial Results
- VerifyMe (VRME) Q4 Earnings Cheat Sheet
- VerifyMe CEO Patrick White departs, Executive Chairman appointed Interim CEO
